NCT02784171 2024-12-10Pembrolizumab in Patients With Advanced Malignant Pleural MesotheliomaCanadian Cancer Trials GroupPhase 2/3 Completed520 enrolled 16 charts 1 FDA
NCT00101283 2023-07-03Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaEastern Cooperative Oncology GroupPhase 2 Completed32 enrolled 8 charts